Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Meihua International Medical Technologies Co EV-to-EBIT?
Meihua International Medical Technologies CoMHUAF 59 EV-to-EBIT is 0.77 as of Jul. 31, 2026, which is 10% below its 10-year median of 0.86. GuruFocus rates MHUAF with a GF Score™ of 59/100 and a GF Value™ of $26.50 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 467 Medical Devices & Instruments companies, Meihua International Medical Technologies Co ranks better than 97.22% on this metric.
Meihua International Medical Technologies Co (OTCPK:MHUAF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Meihua International Medical Technologies Co's Enterprise Value for the quarter that ended in Dec. 2025 was $1.34 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Meihua International Medical Technologies Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $9.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co EV-to-EBIT Related Terms
Meihua International Medical Technologies Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co EV-to-EBIT Chart
Meihua International Medical Technologies Co Annual Data
For the Medical Instruments & Supplies subindustry, Meihua International Medical Technologies Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meihua International Medical Technologies Co EV-to-EBIT vs Medical Devices & Instruments Industry
Meihua International Medical Technologies Co's current Enterprise Value is $7.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Meihua International Medical Technologies Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $9.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co (MHUAF) has a EV-to-EBIT of 0.77 as of Jul. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Meihua International Medical Technologies Co and its competitors. This is 10% below median its historical median of 0.86. According to the industry distribution chart, Meihua International Medical Technologies Co ranks #13 out of 467 companies in the Medical Devices & Instruments industry, placing it in the top 2.8%.
Is Meihua International Medical Technologies Co's EV-to-EBIT too high?
Meihua International Medical Technologies Co's current EV-to-EBIT of 0.77 is 10% below median its 10-year median of 0.86. The Medical Devices & Instruments industry median EV-to-EBIT is 18.66. Meihua International Medical Technologies Co's value of 0.77 is 95.9% below this industry median. Based on the distribution chart, Meihua International Medical Technologies Co ranks #13 out of 467 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Meihua International Medical Technologies Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meihua International Medical Technologies Co's EV-to-EBIT compare to CUPR and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Meihua International Medical Technologies Co ranks #13 out of 467 companies for EV-to-EBIT. This places Meihua International Medical Technologies Co in the top 3% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 18.66. Meihua International Medical Technologies Co's value of 0.77 is 95.9% below this benchmark. While the company's 10-year median is 0.86 vs. the industry median of 18.66, Meihua International Medical Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.66, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meihua International Medical Technologies Co's current EV-to-EBIT of 0.77 is 95.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Meihua International Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meihua International Medical Technologies Co's current EV-to-EBIT is 0.77, which is 10% below median its own 10-year median of 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihua International Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co (MHUAF) is currently considered Possible Value Trap. The stock's GF Value™ is $26.50, compared to a current price of $8.77 — trading 66.9% below its estimated fair value. The current EV-to-EBIT is 0.77, which is 10% below median its 10-year median of 0.86 and 95.9% below the Medical Devices & Instruments industry median of 18.66. Meihua International Medical Technologies Co's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Meihua International Medical Technologies Co (MHUAF), the current EV-to-EBIT is 0.77 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Meihua International Medical Technologies Co (MHUAF) Overvalued in 2026?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co stock appears to be undervalued.
The current stock price of $8.77 is trading 66.9% below its estimated GF Value™ of $26.50.
GuruFocus considers Meihua International Medical Technologies Co to be Possible Value Trap.
Key valuation signals for MHUAF:
EV-to-EBIT: 0.77 (10% below median its 10-year median of 0.86)
GF Value™: $26.50 vs. price of $8.77 (66.9% below fair value)
Industry Position: 95.9% below the Medical Devices & Instruments median (#13 of 467)
No single metric tells the full story. See the MHUAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
59GF Score
Get the complete analysis for MHUAF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MHUAF has been successfully added to your 
